Clinical Trials
64 trialsA Study of Blood Pressure Control During Cancer Treatment
Memorial Sloan Kettering Cancer Center
HER2HEART-US: Prevention of Cardiotoxicity in Breast Cancer Patients Receiving HER2-directed Therapy
Washington University School of Medicine
CARE-BREAST
University of Castilla-La Mancha
Hyperpolarized Carbon 13-Based Metabolic Imaging to Detect Radiation-Induced Cardiotoxicity
University of Texas Southwestern Medical Center
Evaluating 6-months of HER2-targeted Therapy in Patients With HER2 Positive Early-stage Breast Cancer That Achieve a Pathological Complete Response to Neoadjuvant Systemic Therapy
Ottawa Hospital Research Institute
BE-FITTER
University of Alberta
OTT 15-05
Ottawa Hospital Research Institute
ROSUBREAST
Shiraz University of Medical Sciences
ATOPE
Universidad de Granada
Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted
Rutgers, The State University of New Jersey
CCTGuide Pilot
Abramson Cancer Center at Penn Medicine
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
SWOG Cancer Research Network
Evaluation of Possible Safety and Efficacy of Fenofibrate in the Prophylaxis of Doxorubicin Induced Cardiotoxicity in Breast Cancer Patients
Tanta University
PROACT
Washington University School of Medicine
NTproBNP-Guide
Abramson Cancer Center at Penn Medicine
The Effects of Two Exercise Interventions on Breast Cancer Patients Undergoing Cardiotoxic Chemotherapies
University of Virginia
TRUST-ACE
Norwegian University of Science and Technology
CorTox
Technische Universität Dresden
JUSTIFY
Women's College Hospital
Effect of Anthracyclines and Cyclophosphamide on Cardiovascular Responses
University of Sao Paulo General Hospital
CARTIER
Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León
CARPTOX-BC
Instituto Nacional de Cardiologia Ignacio Chavez
Sacubitril/Valsartan in PriMAry preventIoN of the Cardiotoxicity of Systematic breaST canceR trEAtMent (MAINSTREAM)
Silesian Centre for Heart Diseases
CARMA
Cedars-Sinai Medical Center
PROTECT-COR
Erasmus Medical Center
Exercise for Ameliorating Chemotherapy Cardiotoxicity
University of Hull
EXACT2
Nova Scotia Health Authority
CardioProtEx
Technical University of Madrid
PROTECT
Fondazione IRCCS Policlinico San Matteo di Pavia
NT-proBNP to Assess Trastuzumab-induced Cardiotoxicity
Vastra Gotaland Region
BACCARAT
Institut de Radioprotection et de Surete Nucleaire
BRAVEHeart
University of Sydney
Strategy Therapy on Cancer Therapy-Related Cardiac Dysfunction
National Cheng-Kung University Hospital
MRI in Detecting Heart Damage in Patients With Cancer Receiving Chemotherapy With Exercise Capacity Addendum
Wake Forest University Health Sciences
ONCORE
Hospital Clinico Universitario de Santiago
NARNIA
University Hospital, Akershus
Cancer Adverse Effects PReventIon With Care & Exercise: the CAPRICE Study
Insel Gruppe AG, University Hospital Bern
CONTROL
Humanitas Hospital, Italy
The Safety Management of Cardiac Toxicity in Breast Cancer Patients Under Multidiscipline Therapy.
Ruijin Hospital
EDIPE
Institut de cancérologie Strasbourg Europe
Role of Silymarin in Chemotherapy Toxicity and Cognition Improvement in Breast Cancer Patients
Tanta University
Doxorubicin and Cyclophosphamide Followed By Trastuzumab, Paclitaxel, and Lapatinib in Treating Patients With Early-Stage HER2-Positive Breast Cancer That Has Been Removed By Surgery
Mayo Clinic
ANKE
Heinrich-Heine University, Duesseldorf
The Impact of Chronic Mitochondrial Antioxidant Supplementation on CardiovascularToxicity in Breast Cancer Patients
D'Or Institute for Research and Education
SAFE
Azienda Ospedaliero-Universitaria Careggi
Exercise Prescription Guided by Heart Rate Variability in Breast Cancer Patients
GO fit Lab- Ingesport
Lisinopril or Coreg CR® in Reducing Side Effects in Women With Breast Cancer Receiving Trastuzumab
University of South Florida
Evaluation of the Cardioprotective Effect of L-carnitine and Silymarin in Patients Receiving Anthracycline Chemotherapy
Horus University
Strain vs. Left Ventricular Ejection Fraction-based Cardiotoxicity Prevention in Breast Cancer
Samsung Medical Center
Acute Exercise Cardioprotection From Doxorubicin
University of British Columbia